These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10706882)

  • 41. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.
    Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K
    Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity.
    Shudo K; Kinoshita K; Imamura R; Fan H; Hasumoto K; Tanaka M; Nagata S; Suda T
    Eur J Immunol; 2001 Aug; 31(8):2504-11. PubMed ID: 11500835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of fas ligand in uveal melanoma-induced liver damage.
    Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.
    Davidson WF; Giese T; Fredrickson TN
    J Exp Med; 1998 Jun; 187(11):1825-38. PubMed ID: 9607923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells.
    Camacho IA; Hassuneh MR; Nagarkatti M; Nagarkatti PS
    Toxicology; 2001 Aug; 165(1):51-63. PubMed ID: 11551431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of acute lung inflammatory injury to Fas/FasL system.
    Neff TA; Guo RF; Neff SB; Sarma JV; Speyer CL; Gao H; Bernacki KD; Huber-Lang M; McGuire S; Hoesel LM; Riedemann NC; Beck-Schimmer B; Zetoune FS; Ward PA
    Am J Pathol; 2005 Mar; 166(3):685-94. PubMed ID: 15743781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
    Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
    Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth.
    Sata M; Hirata Y; Nagai R
    Hypertens Res; 2002 Jul; 25(4):577-82. PubMed ID: 12358144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.
    Tada Y; O-Wang J; Seimiya M; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
    Anticancer Res; 2002; 22(2A):831-6. PubMed ID: 12014659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
    Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
    J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer.
    Lee JK; Sayers TJ; Back TC; Wigginton JM; Wiltrout RH
    Apoptosis; 2003 Mar; 8(2):151-60. PubMed ID: 12766475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of Fas-mediated apoptosis after traumatic spinal cord injury.
    Yoshino O; Matsuno H; Nakamura H; Yudoh K; Abe Y; Sawai T; Uzuki M; Yonehara S; Kimura T
    Spine (Phila Pa 1976); 2004 Jul; 29(13):1394-404. PubMed ID: 15223929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fas/FasL-mediated apoptosis in perinatal murine lungs.
    De Paepe ME; Mao Q; Embree-Ku M; Rubin LP; Luks FI
    Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L730-42. PubMed ID: 15355863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
    Hohlbaum AM; Moe S; Marshak-Rothstein A
    J Exp Med; 2000 Apr; 191(7):1209-20. PubMed ID: 10748238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
    Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
    J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y; Chen K; Sharp GC; Braley-Mullen H
    J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.